Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04150666

The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Qifu Li · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To investigate whether increasing water intake has renal protective effect on PA patients after surgical treatment.

Detailed description

This is a single-center randomized controlled trial study to verify the effect of drinking water on renal function after PA surgery treatment and to follow up the clinical outcomes. We will take short-term follow-up on whether increasing water intake can improve eGFR decline in the early stage of PA patients after surgical treatment and further long-term follow-up to investigate whether increasing drinking water has long-term memory effect to slow down renal function deterioration and improve clinical outcomes. This study will be completed in 1 year.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHydrationthe same with arm descriptions

Timeline

Start date
2019-12-01
Primary completion
2020-05-01
Completion
2020-12-01
First posted
2019-11-05
Last updated
2020-07-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04150666. Inclusion in this directory is not an endorsement.

The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP) (NCT04150666) · Clinical Trials Directory